RapidAI
RapidAI enables neurovascular and vascular clinical teams to push the boundaries of care, reducing time to treatment and improving patient outcomes.
RapidAI
RapidAI enables neurovascular and vascular clinical teams to push the boundaries of care, reducing time to treatment and improving patient outcomes.
TL;DR
Headcount: 350 employees
Founded / Origin: Evolved from Stanford neuroimaging research (first platform 2008)
Product focus: Clinical AI imaging platform for neurovascular, cardiac, and vascular care
Global reach: Deployed in thousands of hospitals across 100+ countries (company claim)
Recent funding: $75M growth investment (Series C) announced Jul 27, 2023
Company Overview
Problem Domain
Automating and augmenting medical imaging interpretation to accelerate diagnosis and treatment in stroke and other vascular conditions.
Industry
Healthtech / Medical Imaging / Clinical AI
Funding Track Record
$25 million
$75 million
Transaction advised by UBS Securities LLC
Investor Signal
“Led by Vista Credit Partners (Vista Equity Partners affiliate) for Series C; previous lead investor Lennertz & Co. for Series B”